MedTrace Logo

Acetylsalicylic Acid and Type 2 Diabetes Mellitus

NCT03341117 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2017-11-14

No results posted yet for this study

Summary

OBJETIVE To assess the effect of acetylsalicylic acid on antioxidant enzymatic system in patients with type 2 diabetes

Conditions

  • Diabetes Mellitus, Type 2
  • Antioxidant Enzyme System

Interventions

DRUG

Acetylsalicylic acid

Acetylsalicylic acid 300 mg per capsule

DRUG

Calcined magnesia

Calcined magnesia 300 mg per capsule

Sponsors & Collaborators

  • Centro Universitario de Ciencias de la Salud, Mexico

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-02
Primary Completion
2015-12-02
Completion
2016-12-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03341117 on ClinicalTrials.gov